Recruiting
Forearm Immobilization in T2D
The aim of the present study is to assess the impact of short-term forearm immobilization on forearm muscle glucose uptake and amino acid net balance and kinetics in individuals with T2D compared with a control group with normoglycaemia.
ClinicalTrials.gov IDNCT06750497
PhaseNA
Enrollment26
SponsorWageningen University
Age18 Years
SexALL
Conditions studied
Healthy, Type 2 Diabetes
About this study
The aim of the present study is to assess the impact of short-term forearm immobilization on forearm muscle glucose uptake and amino acid net balance and kinetics in individuals with T2D compared with a control group with normoglycaemia.
Interventions
- Behavioral: Forearm immobilization — Two days of forearm immobilization
Primary outcomes
- Change in forearm muscle glucose uptake (From 0 to 48 hours)
Eligibility information
Inclusion criteria
* Males and females with or without diagnosed type 2 diabetes
* Use lifestyle changes, metformin, gliclazide, or a combination thereof as oral glucose-lowering treatments for T2D
* Aged 18-80 years at the time of signing informed consent
* 18.5 ≥ BMI ≤ 35 kg·m2
Exclusion criteria
* Type 1 or a genetic form of diabetes
* Any diagnosed cardiovascular (heart) disease or high blood pressure (≥160 mmHg systolic and/or ≥100 mmHg diastolic)
* Chronic use of any prescribed or over-the-counter pharmaceuticals (excluding oral contraceptives and contraceptive devices) that interact with muscle substrate metabolism (e.g. selective serotonin reuptake inhibitors)
* Consumption of a low-carbohydrate diet
* Smoking or chewing tobacco
* Known anaemia
* Regular use of dietary protein and/or amino acid supplements (\>3 times per week)
* Currently involved in a structured progressive resistance training program (\>3 times per week)
* A personal or family history of thrombosis (clots)
* Any previous motor disorders or inborn errors in muscle and/or lipid metabolism
* History of kidney disease
* History of liver disease
* Pregnant or breastfeeding
* History of any drug or alcohol abuse in the past two years
* Claustrophobia
* Unable to give consent
Study locations
- Wageningen University and Research, Wageningen, Gelderland 6708WD Netherlands
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.